EN
HI-4 KIT is an Medical Device (Risk Class IIa - MMD 93/42/EEC
and subsequent changes) highly efficient in medical therapies
administered by means of aerosol nebulization. This device is
designed for the nebulization of for atomising antibiotics and
bronchodilator drugs (distribution of drugs with aerosol
therapy).
WARNINGS - GENERAL SAFETY REGULATIONS
Please read the instructions carefully before use.
Keep the instructions in a safe place.
Always observe instructions and safety warnings as
indicated in the instructions manuals of devices for
aerosoltherapy. The device should be used only original
accessories shown in this manual.
The device has small components which might be removed
and easily swallowed. Use by minors and disabled people
require presence of an adult with his faculties. Don't leave the
device unattended in places easily accessible by minors and
disabled people.
Dispose of device ads provided by standards in force.
This medical device must be destined exclusively for the use for
which it has been designed ad described in this manual.
Device not suitable for anaesthesia and lung ventilation.
In presence of pathologies with microbial contamination and
infection hazard a single-patient use of accessories and
nebulizer is recommended (always consult your doctor).
The device should be used only with compressor for
aerosoltherapy that comply with standards in force.
Use the "nose piece" accessory only if expressly indicated by
your doctor and paying attention NEVER to introduce inside
the nose the nasal bifurcation, but only bring it as close as
possible.
The materials used to contain the drugs are made with highly
stable thermoplastic polymers that are resistant against che-
micals. Such materials were tested with commonly used
drugs (Salbutamol, Beclametasone dipropionate,
Acetylcysteine, Budesonide, Ambroxol) and no interaction
phenomenon was observed. Interactions cannot however be
excluded given the variety and the continuous evolution of
the drugs that are used. Remember to:
o
To consume the drugs as quickly as possible after opening
its package;
o
To avoid keeping the drug in the tray-like container for too
long and to clean it immediately after every application;
o
If the tray-like container presents any abnormal situation
(such as softening or cracks), do not introduce any solution
and do not proceed with the inhalation. Contact the
Please read the instructions carefully before use.
Drug Administration must be under medical
control.
10